Skip to main content
. 2023 May 5;23:318. doi: 10.1186/s12884-023-05630-5

Table 1.

Clinical characteristics of women with GDM and non-GDM

Characteristics Mean ± SD or N (%) P
GDM group (n = 1632) non-GDM group (n = 9067)
Maternal Age (years) 33.02 ± 4.36 30.80 ± 4.53  < 0.001
 20–29 425(26.04) 3835(42.30)  < 0.001
 30–34 650(39.83) 3409(37.60)
  ≥ 35 557(34.13) 1823(20.10)
Pre-pregnancy BMI (kg/m2) 21.64 ± 2.94 20.66 ± 2.64  < 0.001
 Underweight (< 18.5) 228(13.97) 1804(19.90)  < 0.001
 Normal weight (18.5–24.9) 1215(74.45) 6683(73.71)
 Overweight and obese (≥ 25.0) 189(11.58) 580(6.40)
Gestational weight gain
 Appropriate 696(42.65) 3752(41.38)  < 0.001
 Inadequate 612(37.50) 3991(44.02)
 Excessive 324(19.85) 1324(14.60)
Maternal education [n (%)]
  ≤ Junior school 165(10.11) 917(10.11) 0.896
  High school 199(12.19) 1162(12.82)
  ≥ University 1268(77.69) 6988(77.07)
 Caesarean history [n (%)] 402(24.63) 2531(27.91)  < 0.001
Parity
 Nulliparous 861(52.76) 5495(60.60)  < 0.001
 Multiparous 771(47.24) 3572(39.40)
 IVF [n (%)] 176(10.78) 621(6.85)  < 0.001
Mode of delivery [n (%)]
 Vaginal 890(54.53) 5423(59.81)  < 0.001
 Cesarean 742(45.47) 3644(40.19)
 Gestational age (weeks, mean ± SD) 38.35 ± 1.75 37.58 ± 2.67  < 0.001
 FPG on OGTT (mmol/L) 5.59 ± 0.83 4.12 ± 0.47  < 0.001
 2-h blood glucose on OGTT (mmol/L) 8.75 ± 1.69 7.21 ± 1.92  < 0.001

GDM Gestational Diabetes Mellitus, IVF In-vitro fertilization, FPG Fasting plasma glucose, OGTT Oral glucose tolerance test

SD Standard deviation, pp BMI Pre-pregnancy body mass index, IVF In-vitro fertilization, FBG Fasting Plasma Glucose, OGTT Oral glucose tolerance test